Key result
CCR2+ macrophages replace ~70% of resident cells in autoimmune myocarditis, driving pro-inflammatory stromal activation.
Why the study?
Autoimmune myocarditis frequently progresses to inflammatory cardiomyopathy through dysregulated immune-stromal interactions.
Population
46,233 cardiac nuclei from the experimental autoimmune myocarditis mouse model
Comparison
Four timepoints: day 0 (healthy), day 14 (inflammation), day 21 (acute inflammation), and day 40 (late cardiac remodelling)
Design
Preclinical single-nuclei RNA-sequencing study
Follow-up
Day 40
Authors
Loading...
Hypothesis-generating for macrophage dynamics in myocarditis; human validation required before clinical relevance.
Single-nuclei RNA sequencing of an experimental autoimmune myocarditis mouse model reveals dynamic shifts from tissue-resident to recruited pro-inflammatory macrophages, highlighting potential therapeutic targets like CCR2-mediated recruitment.
Stefańska et al. (2026) studied Experimental autoimmune myocarditis. Experimental autoimmune myocarditis progression vs. Healthy state (day 0) was evaluated on Macrophage heterogeneity and cell-cell communication. During experimental autoimmune myocarditis, tissue-resident macrophages (~55% at baseline) are rapidly replaced by recruited CCR2+ macrophages (>70%) driving pro-inflammatory stromal activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: